<- Go Home

Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Market Cap

$25.5M

Volume

57.9K

Cash and Equivalents

$1.2M

EBITDA

-$8.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$74.0K

Profit Margin

100.00%

52 Week High

$9.00

52 Week Low

$2.74

Dividend

N/A

Price / Book Value

9.16

Price / Earnings

-12.83

Price / Tangible Book Value

15.25

Enterprise Value

$24.3M

Enterprise Value / EBITDA

-2.97

Operating Income

-$8.2M

Return on Equity

832.21%

Return on Assets

-162.14

Cash and Short Term Investments

$1.2M

Debt

N/A

Equity

$2.8M

Revenue

$74.0K

Unlevered FCF

-$3.8M

Sector

Health Care Technology

Category

N/A

Company Stock Pitches